Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | PEPD | P12955 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1677255 | 1.00 | — | — | |
| SCHEMBL7551227 | 1.00 | CA4 (0.48) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL27992964 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL11824228 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| Water SCHEMBL28230185 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL9507970 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL15261874 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL28016664 | 0.97 | CA4 (0.46) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL16795494 | 0.97 | CA4 (0.50) | CA4PEPDALDH1A1TSHRTDP1 | |
| SCHEMBL49771 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114767734-B | Motherwort extract and application thereof in lowering blood pressure and blood fat | 沈阳永大制药股份有限公司 | 2023-01-24 | — | — | CN | claimed |
| CN-114767734-A | Motherwort extract and application thereof in lowering blood pressure and blood fat | 王晓娟 | 2022-07-22 | — | — | CN | claimed |
| CN-107375996-A | A kind of Biofunctional dressing and preparation method thereof | 长沙海润生物技术有限公司 | 2017-11-24 | — | — | CN | claimed |
| CN-114767734-B | Motherwort extract and application thereof in lowering blood pressure and blood fat | 沈阳永大制药股份有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-114767734-A | Motherwort extract and application thereof in lowering blood pressure and blood fat | 王晓娟 | 2022-07-22 | — | — | CN | disclosed |
| CN-107375996-A | A kind of Biofunctional dressing and preparation method thereof | 长沙海润生物技术有限公司 | 2017-11-24 | — | — | CN | disclosed |
| US-8377979-B2 | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2013-02-19 | — | — | US | disclosed |
| US-20130017254-A1 | PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2013-01-17 | — | — | US | disclosed |
| US-20070185180-A1 | Pharmaceutical formulation containing phenytoin sodium and magnesium stearate | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2007-08-09 | — | — | US | disclosed |
| WO-2007067508-A2 | PHARMACEUTICAL FORMULATION CONTAINING PHENYTOIN SODIUM AND MAGNESIUM STEARATE | TARO PHARMACEUTICALS NORTH AMERICA, INC. (KY) | 2007-06-14 | — | — | WO | disclosed |